Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
High-flow nasal cannula (HFNC) enables delivering humidified gas at high-flow rates controlling the oxygen inspired fraction (FiO2). Its efficacy has been demonstrated in hypoxemic acute respiratory failure. However, little is known about its use in hypercapnic acute respiratory failure (ARF). Therefore, we aimed to evaluate the effect of using HFNC through "Precision Flow" equipment as first line of ventilatory support for COPD patients with hypercapnic acute respiratory failure.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Need for non-invasive ventilation | The need and causes for non-invasive ventilation will be recorded in the all study period. | From inclussion study date until the first day of noninvasive ventilation use documented, after high flow oxygen therapy use or death date from any cause, whichever came first, assessed up to 4 weeks. |
| Need for endotracheal intubation | The need and causes for endotracheal intubation will be recorded in the all study period. | From inclussion study date until the first day of endotracheal intubation documented, after high flow oxygen therapy use or death date from any cause, whichever came first, assessed up to 4 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Gas Exchange | pH will be recorded | Arterial blood gases will be recorded 1, 24 hours and every 24 hours after enrollment |
| Gas Exchange | PaCO2 in milimeters of mercury (mmHg) will be recorded |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Moderate to very severe COPD patients (GOLD 2 to 4) admitted to the ICU with acute hypercapnic respiratory failure
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gustavo A Plotnikow | Sanatorio Anchorena Recoleta | Study Director |
| Mariano Setten | Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC) | Principal Investigator |
| Norberto Tiribelli | Complejo Médico Policial Churruca-Visca | Principal Investigator |
| Sebastian Fredes | Sanatorio de la Trinidad Mitre | Principal Investigator |
| Matias Accoce | Sanatorio Anchorena San Martín | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sanatorio Anchorena | CABA | 1425 | Argentina |
Not provided
| ID | Term |
|---|---|
| D012131 | Respiratory Insufficiency |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Arterial blood gases will be recorded 1, 24 hours and every 24 hours after enrollment |
| Gas Exchange | PaO2 in milimeters of mercury (mmHg) will be recorded | Arterial blood gases will be recorded 1, 24 hours and every 24 hours after enrollment |
| Respiratory variables | Respiratory rate in numbers of breaths per minute (bpm) will be recorded | Respiratory variables will be recorded at 1, 2, 3, 6, 12, 24 hours and every 24 hours after enrollment |
| Respiratory variables | Accessory muscular use (intercostal or supraclavicular) by "YES or NO" will be recorded | Respiratory variables will be recorded at 1, 2, 3, 6, 12, 24 hours and every 24 hours after enrollment |
| Respiratory variables | Thoraco-abdominal asynchrony by "YES or NO" will be recorded | Respiratory variables will be recorded at 1, 2, 3, 6, 12, 24 hours and every 24 hours after enrollment |
| Patient's discomfort | Discomfort related to the high flow oxygen therapy and related to the degree of humidification will be assessed by using a numerical rating scale from 1 (no discomfort) to 5 (maximum imaginable discomfort). Patients will be asked to rate their discomfort with the used device and discomfort symptoms will be determined for the dryness of the delivered oxygen (dryness of the mouth, throat, nose, difficulty to swallow and throat pain). | Patient's discomfort will be recorded at 1, 2, 3, 6, 12, 24 hours and every 24 hours after enrollment |